LINDON, Utah, Jan. 24, 2018 -- Dr. Vaughn R Cook, CEO of ZYTO (OTC PINK:ZYTO), provided the keynote address to a room packed with Eastern medicine practitioners at the Functional Medicine Conference in Shanghai, China, this month. In the presentation, Dr. Cook instructed attendees how to incorporate ZYTO into a functional medical practice with technologies like biocommunication to obtain specific information from the body and then, using a vectored approach, filter the information to provide insights about individual patients.
|
|||||
This is the third time during the past 12 months that Dr. Cook has been invited to present technologies that were developed in the United States to functional medicine practitioners in China. Because ZYTO technology incorporates concepts of both Eastern and Western approaches to wellness into a software platform, many people in Asia see ZYTO technology as an enhancement of traditional concepts that helps to make better decisions, faster.
“I am very honored to share these insights with our friends in China,” said Dr. Cook. “There is a rich history with regards to medical practices in China. With new technology, we can help to preserve these concepts and enable their use for a whole new generation of people interested in energetic and functional medicine.”
About ZYTO
ZYTO is a technology company founded in 2004 by Dr. Vaughn R Cook. The company provides biocommunication hardware and software with wellness and lifestyle applications that include obtaining and analyzing galvanic skin response data from the human body to assist in making better decisions.
Forward-looking statements in this release are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to marketing and sales activities by ZYTO’s marketing partners, ZYTO product development launches, future growth and research, and enhanced value for ZYTO’s stockholders are forward-looking statements. Such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company’s products, increased levels of competition, new products and technological changes, dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time. ZYTO disclaims any obligation or intention to update any forward-looking statement contained in this release.
Contact Information
Any questions regarding this release can be directed to:
Adam Ford
ZYTO Corporation General Counsel
[email protected]
www.ZYTO.com
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/d84e3583-f7d7-441c-a7ed-504da2e4ea7a


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Washington Post Publisher Will Lewis Steps Down After Layoffs
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Amazon Explores AI Content Marketplace With Media Publishers
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



